Minimally Invasive Devices, Inc. (MID), a Columbus, Ohio-based developer and manufacturer of the FloShield™ laparoscopic vision system, raised an additional $2.5m in Series B financing.
Radius Ventures joined Canaan Partners and Charter Life Sciences, which previously invested $9m (read here).
The company intends to use the funds for sales and marketing, clinical studies, the generation of outcomes data and additional product development.
Led by Wayne Poll, MD, founder and CEO, Minimally Invasive Devices has developed a device that prevents loss of vision during laparoscopic surgery due to obscuration of the optics.
FloShield™ attaches to modern HD vision systems, enabling surgery to occur without interruption, loss of vision, or the need to remove the scope for cleaning.
FinSMEs
17/07/2013